By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Teva Pharmaceutical Industries Limited 

5 Basel Street

Petach Tikva    49131  Israel
Phone: 972-3-9267-267 Fax: 972-3-9234-050



Company News
Teva (TEVA) Beats Rivals by Snapping Up Mexico's Rimsa for $2.3 Billion 10/1/2015 11:00:56 AM
Healthbox Portfolio Company Gecko Health Innovations Is Acquired By Teva (TEVA) 9/30/2015 11:08:33 AM
Important New Data From Teva (TEVA)'s TEV-48125 Phase IIB Migraine Program Published In Lancet Neurology In Back-To-Back Articles 9/30/2015 10:51:13 AM
Teva (TEVA) Announces Approval Of COPAXONE In Japan For The Prevention Of Relapse Of Multiple Sclerosis 9/28/2015 2:14:26 PM
Teva (TEVA) Presents New Reslizumab Data At European Respiratory Society (ERS) International Congress 2015 9/28/2015 1:37:54 PM
Teva (TEVA) Reinforces Leadership Position In Respiratory With Acquisition Of Gecko Health Innovations 9/25/2015 8:37:05 AM
Teva (TEVA) Announces FDA Acceptance Of A Supplemental New Drug Application For Proair Respiclick (Albuterol Sulfate) Inhalation Powder For Pediatric Patients 9/10/2015 10:32:18 AM
Teva (TEVA) And IBM (IBM)Partner To Build Global E-Health Solutions On The IBM Watson Health Cloud 9/10/2015 9:56:02 AM
Teva (TEVA) Introduces “Design For Dialogue” To Support Patient-Doctor Conversations On Responsible Pain Management 9/8/2015 11:14:49 AM
Teva (TEVA) Announces U.S. Availability Of ZECUITY (Sumatriptan Iontophoretic Transdermal System), First And Only Transdermal Patch System For The Acute Treatment Of Migraine 9/1/2015 11:10:22 AM